Rockefeller University
New York, New York, United States
Purpose
to test the hypothesis that, given with antiretroviral therapy upon HIV diagnosis, bNAbs against HIV will induce an immune response leading to durable suppression of the disease once antiretroviral therapy is discontinued
Division
Global Health
Date
November 2022
Region Served
GLOBAL
Committed amount
$9,889,980
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
58
Grantee location
New York, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.